A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors
Clinical trial NCT03708211 · COMPLETED
Trial details
- NCT number
- NCT03708211
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-28
- Primary completion
- 2019-12-03
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.